135 related articles for article (PubMed ID: 35485715)
1. Antipsychotic polypharmacy and adverse drug reactions among adults in a London mental health service, 2008-2018.
Yang JC; Thygesen JH; Werbeloff N; Hayes JF; Osborn DPJ
Psychol Med; 2023 Jul; 53(9):4220-4227. PubMed ID: 35485715
[TBL] [Abstract][Full Text] [Related]
2. Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.
Kadra G; Stewart R; Shetty H; Jackson RG; Greenwood MA; Roberts A; Chang CK; MacCabe JH; Hayes RD
BMC Psychiatry; 2015 Jul; 15():166. PubMed ID: 26198696
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.
Ayani N; Morimoto T; Sakuma M; Kikuchi T; Watanabe K; Narumoto J
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):397-402. PubMed ID: 34108429
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
Burness C; Corbet C; Beyene K; Webby C; Nankivell C; Cabasag P; Hari K; Fraser A; Gray S; Harrison J; Chan AHY
Psychiatry Res; 2021 Aug; 302():113996. PubMed ID: 34126462
[TBL] [Abstract][Full Text] [Related]
6. Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality.
Kadra G; Stewart R; Shetty H; MacCabe JH; Chang CK; Taylor D; Hayes RD
Acta Psychiatr Scand; 2018 Aug; 138(2):123-132. PubMed ID: 29845597
[TBL] [Abstract][Full Text] [Related]
7. Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.
Kadra G; Stewart R; Shetty H; Downs J; MacCabe JH; Taylor D; Hayes RD
Schizophr Res; 2016 Jul; 174(1-3):106-112. PubMed ID: 27091655
[TBL] [Abstract][Full Text] [Related]
8. Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.
Rani FA; Byrne PJ; Murray ML; Carter P; Wong IC
Drug Saf; 2009; 32(4):325-33. PubMed ID: 19388723
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of antipsychotic polypharmacy.
Gallego JA; Nielsen J; De Hert M; Kane JM; Correll CU
Expert Opin Drug Saf; 2012 Jul; 11(4):527-42. PubMed ID: 22563628
[TBL] [Abstract][Full Text] [Related]
10. Safety of antipsychotics in people with intellectual disability.
Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
[TBL] [Abstract][Full Text] [Related]
11. Using an Integrated Care Pathway for Late-Life Schizophrenia Improves Monitoring of Adverse Effects of Antipsychotics and Reduces Antipsychotic Polypharmacy.
Abdool PS; Supasitthumrong T; Patel K; Mulsant BH; Rajji TK
Am J Geriatr Psychiatry; 2019 Jan; 27(1):84-90. PubMed ID: 30396766
[TBL] [Abstract][Full Text] [Related]
12. Mortality risk from long-term treatment with antipsychotic polypharmacy vs monotherapy among adults with serious mental illness: A systematic review and meta-analysis of observational studies.
Buhagiar K; Templeton G; Blyth H; Dey M; Giacco D
Schizophr Res; 2020 Sep; 223():18-28. PubMed ID: 32948381
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic polypharmacy prescribing and risk of hospital readmission.
Kadra G; Stewart R; Shetty H; MacCabe JH; Chang CK; Kesserwani J; Taylor D; Hayes RD
Psychopharmacology (Berl); 2018 Jan; 235(1):281-289. PubMed ID: 29080904
[TBL] [Abstract][Full Text] [Related]
14. Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare.
Kadra G; Spiros A; Shetty H; Iqbal E; Hayes RD; Stewart R; Geerts H
J Psychopharmacol; 2018 Nov; 32(11):1191-1196. PubMed ID: 30232932
[TBL] [Abstract][Full Text] [Related]
15. Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.
Matsui K; Tokumasu T; Takekita Y; Inada K; Kanazawa T; Kishimoto T; Takasu S; Tani H; Tarutani S; Hashimoto N; Yamada H; Yamanouchi Y; Takeuchi H
Schizophr Res; 2019 Jul; 209():50-57. PubMed ID: 31182319
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
17. Admission to acute mental health services after contact with crisis resolution and home treatment teams: an investigation in two large mental health-care providers.
Werbeloff N; Chang CK; Broadbent M; Hayes JF; Stewart R; Osborn DPJ
Lancet Psychiatry; 2017 Jan; 4(1):49-56. PubMed ID: 27979719
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic Polypharmacy in Older Adult Asian Patients With Schizophrenia: Research on Asian Psychotropic Prescription Pattern.
Dong M; Zeng LN; Zhang Q; Yang SY; Chen LY; Sim K; He YL; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK; Ng CH; Ungvari GS; Xiang YT
J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):304-311. PubMed ID: 31480982
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic polypharmacy in older Australians.
Kalisch Ellett LM; Pratt NL; Kerr M; Roughead EE
Int Psychogeriatr; 2018 Apr; 30(4):539-546. PubMed ID: 29122047
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.
Bighelli I; Rodolico A; Siafis S; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014383. PubMed ID: 36042158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
